|
US6858614B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenolic guanidine sodium channel blockers
|
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
|
US6903105B2
(en)
|
2003-02-19 |
2005-06-07 |
Parion Sciences, Inc. |
Sodium channel blockers
|
|
KR20060037450A
(ko)
|
2003-08-18 |
2006-05-03 |
패리온 사이언스 인코퍼레이티드 |
사이클릭 피라지노일구아니딘 나트륨 채널 차단제
|
|
US20050090505A1
(en)
|
2003-08-18 |
2005-04-28 |
Johnson Michael R. |
Methods of reducing risk of infection from pathogens
|
|
PT1663235E
(pt)
|
2003-08-18 |
2013-10-29 |
Parion Sciences Inc |
Novos bloqueadores dos canais do sódio de pirazinoílguanidina protegida
|
|
WO2005025496A2
(en)
|
2003-08-18 |
2005-03-24 |
Parion Sciences, Inc. |
Aliphatic pyrazinoylguanidine sodium channel blockers
|
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
|
US7399766B2
(en)
|
2004-08-18 |
2008-07-15 |
Parion Sciences, Inc. |
Soluble amide & ester pyrazinoylguanidine sodium channel blockers
|
|
US7807834B2
(en)
|
2005-08-03 |
2010-10-05 |
Parion Sciences, Inc. |
Capped pyrazinoylguanidine sodium channel blockers
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
GB0526240D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
WO2008124491A1
(en)
|
2007-04-03 |
2008-10-16 |
Parion Sciences, Inc. |
Pyrazinoylguanidine compounds for use taste modulators
|
|
ES2361595T3
(es)
|
2007-05-07 |
2011-06-20 |
Novartis Ag |
Compuestos orgánicos.
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
CN101939054B
(zh)
|
2007-12-10 |
2014-10-29 |
诺华股份有限公司 |
有机化合物
|
|
AU2009246799B2
(en)
|
2008-02-26 |
2014-02-27 |
Parion Sciences, Inc. |
Poly aromatic pyrazinoylguanidine sodium channel blockers
|
|
CA2723938A1
(en)
|
2008-05-13 |
2009-11-19 |
Novartis Ag |
3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
|
|
KR20110040818A
(ko)
|
2008-06-10 |
2011-04-20 |
노파르티스 아게 |
상피 나트륨 채널 차단제로서의 피라진 유도체
|
|
WO2011028740A1
(en)
|
2009-09-03 |
2011-03-10 |
Glaxo Group Limited |
ENaC BLOCKERS
|
|
WO2011079087A1
(en)
|
2009-12-23 |
2011-06-30 |
Glaxo Group Limited |
Enac blockers
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
ME02905B
(me)
|
2011-11-02 |
2018-10-20 |
Boehringer Ingelheim Int |
Heterociklična jedinjenja, medikamenti koji sadrže navedena jedinjenja, njihova primjena i postupak za njihovo dobijanje
|
|
US8859559B2
(en)
|
2011-12-20 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
Substituted pyrazines and their use in the treatment of disease
|
|
EP3366680B1
(en)
|
2012-05-29 |
2020-05-13 |
Parion Sciences, Inc. |
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
|
|
US8841309B2
(en)
|
2012-09-24 |
2014-09-23 |
Boehringer Ingelheim International Gmbh |
Substituted pyrazines and their use in the treatment of disease
|
|
BR112015014178A2
(pt)
|
2012-12-17 |
2017-07-11 |
Parion Sciences Inc |
compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
|
|
JP6353032B2
(ja)
|
2013-04-30 |
2018-07-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジアミノピラジン化合物、前記化合物を含有する医薬、その使用、およびその調製方法
|
|
KR20160054460A
(ko)
|
2013-07-02 |
2016-05-16 |
더 캘리포니아 인스티튜트 포 바이오메디칼 리써치 |
낭성 섬유증의 치료를 위한 화합물
|
|
WO2015003958A1
(en)
|
2013-07-08 |
2015-01-15 |
Boehringer Ingelheim International Gmbh |
Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways
|
|
EP3022196B1
(en)
|
2013-07-15 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Novel benzimidazolium compounds
|
|
EP3022197B1
(en)
|
2013-07-15 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Novel tetra- and pentasubstituted benzimidazolium compounds
|
|
JP6461948B2
(ja)
|
2013-07-15 |
2019-01-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規５−置換ベンゾイミダゾリウム化合物
|
|
JP6449880B2
(ja)
|
2013-08-08 |
2019-01-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ピラジンアミド化合物
|
|
US9981954B2
(en)
|
2015-01-12 |
2018-05-29 |
Boehringer Ingelheim International Gmbh |
2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors
|
|
JP6667538B2
(ja)
|
2015-01-12 |
2020-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系疾患の治療に有用な置換ベンズイミダゾリウム化合物
|
|
US20180002312A1
(en)
|
2015-01-12 |
2018-01-04 |
Boehringer Ingelheim International Gmbh |
Tetra- and pentasubstituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
WO2016113167A1
(en)
|
2015-01-12 |
2016-07-21 |
Boehringer Ingelheim International Gmbh |
Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
MY194711A
(en)
|
2015-08-20 |
2022-12-15 |
Boehringer Ingelheim Int |
Novel annelated phenoxyacetamides
|
|
EA201890532A1
(ru)
|
2015-08-20 |
2018-09-28 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые аннелированные бензамиды
|
|
GB201610854D0
(en)
*
|
2016-06-21 |
2016-08-03 |
Entpr Therapeutics Ltd |
Compounds
|
|
GB201619694D0
(en)
*
|
2016-11-22 |
2017-01-04 |
Entpr Therapeutics Ltd |
Compounds
|